Search Results - "Gonzalez A, Olid"
-
1
PMU37 Towards Joint Decision Making: The Need for a Framework to Address Asymmetrical VALUE
Published in Value in health (01-12-2020)Get full text
Journal Article -
2
-
3
POSA254 An Initial Framework to Describe and Classify Integrated Scientific Advice Procedures for Vaccines
Published in Value in health (01-01-2022)Get full text
Journal Article -
4
RWD143 Update of Our Review of Real-World Evidence in HTA Decision-Making of Gene Therapies in the US, Canada, UK, EU4, and Japan
Published in Value in health (01-06-2024)Get full text
Journal Article -
5
HTA35 Selection of Appropriate Endpoints for the EU JCA and National Assessments in Select Member States and England for ATMPs
Published in Value in health (01-06-2024)Get full text
Journal Article -
6
PCR90 Patient Voice and Patient Engagement in Value Assessment Frameworks and HTA Decision-Making for Gene Therapies
Published in Value in health (01-06-2024)Get full text
Journal Article -
7
-
8
HTA34 A Review of Real-World Evidence in Health Technology Assessment Decision-Making of Gene Therapies in the US, Canada, UK, EU4, and Japan
Published in Value in health (01-06-2023)Get full text
Journal Article -
9
HPR124 A Review of Managed Entry Agreements and Innovative Payment Models Established for Gene Therapies in the UK, EU4, US, Canada, and Japan
Published in Value in health (01-06-2023)Get full text
Journal Article -
10
HTA50 HTA Bodies Acceptance of Indirect Treatment Comparisons for Gene Therapies in US, England and Wales, France and Germany
Published in Value in health (01-06-2023)Get full text
Journal Article -
11
HTA269 What Are the Emerging State-of-the-Art HTA Methods That Are Relevant to Harmonization of HTA Across Jurisdictions?
Published in Value in health (01-12-2022)Get full text
Journal Article -
12
PNS285 EVOLVING MHEALTH REIMBURSEMENT LANDSCAPES: WHERE SHOULD COMPANIES LOOK TO?
Published in Value in health (01-11-2019)Get full text
Journal Article -
13
PMD31 PERFORMANCE-BASED RISK SHARING AGREEMENTS: DO PAYERS CONSIDER MEDICINES AND MEDICAL DEVICES DIFFERENTLY?
Published in Value in health (01-11-2019)Get full text
Journal Article -
14
PMD48 OPPORTUNITIES AND CHALLENGES FOR NOVEL MEDICAL DEVICES LAUNCHING IN EUROPE IN THE HOSPITAL SETTING
Published in Value in health (01-11-2019)Get full text
Journal Article -
15
PNS162 An Initial Framework to Describe and Classify Integrated Scientific Advice Procedures: Trends and Developments
Published in Value in health (01-12-2020)Get full text
Journal Article -
16
PRO27 IMPLICATIONS OF INDICATION EXPANSION OF ORPHAN DESIGNATED DRUGS ON EXISTING PRICES ACROSS EUROPEAN MARKETS
Published in Value in health (01-11-2019)Get full text
Journal Article -
17
PBI50 LEVERAGING OUTCOME BASED AND PORTFOLIO AGREEMENTS TO GUARANTEE CLINICAL OUTCOMES: INNOVATIVE PAYMENT MODELS FOR HIGH COST ONE-TIME TREATMENTS
Published in Value in health (01-11-2019)Get full text
Journal Article -
18
PMH50 - TREATMENT OF OPIOID USE DISORDER IN ITALY: IS THERE SCOPE FOR POLICY CHANGE?
Published in Value in health (01-10-2018)Get full text
Journal Article -
19
PMH49 - LAUNCHING LONG ACTING PRODUCTS TO TREAT OPIOID USE DISORDER: ARE PAYERS WILLING TO PAY PREMIUM PRICE?
Published in Value in health (01-10-2018)Get full text
Journal Article